Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium.

Investors reacted positively to Edwards’ 2026 guidance with shares up 1.25% in after-hours trading following the announcement.

Philips stock surged on the NYSE after it reported Street-beating Q4 2025 results and forecast comparable sales growth of 3–4 ...

Zoll announced today that it received CE mark approval under European Medical Device Regulation (MDR) for its Zenix ...

Zimmer Biomet (NYSE: ZBH) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

Boston Scientific has announced new data backing its Farapulse pulsed field ablation (PFA) platform for treating AFib.

Vesalio expanded its neurovascular portfolio today after earning CE mark certification for two new devices: NeVa VS and Neva 3.0 mm.

Medtronic should see its product cycle move the needle on growth, according to Needham & Co. analysts, who have upped their rating on MDT shares to Buy ...

CorTec today announced the second successful implantation of its Brain Interchange brain-computer interface (BCI) system. The procedure took place in an FDA-approved clinical trial involving stroke ...

BD (NYSE: BDX) shares dipped before hours today despite first-quarter results that came in ahead of the consensus Wall Street ...

TransMedics (Nasdaq:TMDX) received FDA investigational device exemption (IDE) for its next-generation OCS ENHANCE Heart trial.

With ReadyFix, GE HealthCare aims to support physicians in providing continuous care for patients by reducing device-related ...